Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

NKTR — Nektar Therapeutics Dilution Risk Tracker

Track NKTR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NKTR — Get alerts when the score changes →

As of October 13, 2026, Nektar Therapeutics (NKTR) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Nektar Therapeutics has a market capitalization of $1.41B, 34.14M shares outstanding, 209 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $250.00M, 293.1K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
32
💰 Cash Runway
95
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 39%
💰 Capital Raise model 73%
• Critical: only 2.4 months cash remaining
• Active ATM program with $250M remaining capacity
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track NKTR — Get forecast alerts →

Market Data

Market Cap$1.41B
Shares Outstanding34.14M
Float21.31M
Cash$39.27M
Debt$133.50M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding34.14MVerified float table or market cache
Public Float21.31MVerified float table or market cache
Market Cap$1.41BMarket data cache
Cash Runway2.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$250.00MSEC-derived dilution fields
Outstanding Warrants293.1KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 2, 424B5 2, 8-K 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 58.2% shares (2026Q1 vs prior)
209 institutional holders · 31.43M shares
#1 FMR LLC 4.30M shares
#2 BVF INC/IL 2.56M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 2.39M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.97M
Days to Cover3.8
% of Float32.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2012-02-29
424B5 ATM 2026-04-20
4 INSIDER TRANSACTION 2026-02-20
4 INSIDER TRANSACTION 2026-02-20
424B5 ATM 2026-02-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NKTR Dilution Snapshot

Nektar Therapeutics (NKTR) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NKTR's DilutionScore is currently 65/100 (High risk), with 2 score changes tracked over 89 days. The score improved from 38/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202665/100HIGH53 days
Jul 17 – Aug 21, 202638/100MEDIUM35 days
Jul 16, 202637/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NKTR shares outstanding have increased 20.8% from 27.98M (Mar 2026) to 33.79M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 28, 202633.79M21.31M▲ 0.02%
May 24, 202633.79M21.31M▼ 0.09%
May 18, 202633.79M21.33M▼ 8.09%
May 10, 202633.74M23.20M▼ 13.78%
May 04, 202633.74M26.91M▲ 0.15%
Apr 28, 202633.21M26.87M▲ 0.11%
Apr 26, 202633.21M26.84M▲ 7.41%
Apr 20, 202628.69M24.99M▼ 7.27%
Mar 17, 202627.98M26.95M▲ 41.57%
Mar 14, 202627.98M19.04M▼ 0.22%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NKTR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NKTR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NKTR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NKTR
NKTR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.